Literature DB >> 25912571

Demodex folliculorum in polycystic ovary syndrome patients.

D Benk Silfeler1, R Keskin Kurt, O A Kaya, E Yengil, B Hamamci, A G Okyay, A Beyazit.   

Abstract

OBJECTIVE: In this study, we aimed to investigate frequency of Demodex (D.) folliculorum infestation in Polycystic Ovary Syndrome patients. PATIENTS AND METHODS: The study population consisted of 30 PCOS patients and 30 matched healthy control subjects admitted to the Hospital of Mustafa Kemal University, Gynecology and Obstetrics Clinic between March 2013 and January 2014. The demographic characteristics of the patients were recorded. Samples from the face region of the subjects were taken by standard method of superficial skin biopsy and evaluated by microscopy. Presence of five or more D. species in a cm2 was considered as positive.
RESULTS: There were no significant differences in age, body mass index, diabetes mellitus incidence between PCOS patients and the control group. However, D. folliculorum infestation was found to increased in PCOS patients (n = 9; 30%) when compared to the control group (n = 2; 6, 7%) (p: 0.04).
CONCLUSIONS: Our study results revealed that Demodex folliculorum appearance increased in PCOS patients.

Entities:  

Mesh:

Year:  2015        PMID: 25912571

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Shared Makeup Cosmetics as a Route of Demodex folliculorum Infections.

Authors:  Aleksandra Sędzikowska; Katarzyna Bartosik; Renata Przydatek-Tyrajska; Monika Dybicz
Journal:  Acta Parasitol       Date:  2021-01-19       Impact factor: 1.440

2.  Investigation of Demodex folliculorum frequency in patients with polycystic ovary syndrome.

Authors:  Ayla Eser; Seval Erpolat; Ikbal Kaygusuz; Hatice Balci; Aydin Kosus
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

3.  Genome-wide association study for SNPs associated with PCOS in human patients.

Authors:  Li Chen; Ling-Min Hu; Yu-Feng Wang; Hai-Yan Yang; Xiao-Yang Huang; Wei Zhou; Hai-Xiang Sun
Journal:  Exp Ther Med       Date:  2017-09-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.